SARS-CoV-2のP.1株による抗体回避
Wanwisa Dejnirattisai1, Daming Zhou2, Piyada Supasa1
1Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Cell
|April 14, 2021
まとめ
P.1 と B.1.351 のような新しいSARS-CoV-2変種は,ACE2結合に影響する変異を有する. モノクローナル抗体222は,これらの変異体を中和し,その軽鎖は,それらに対する抗体の効力を回復させることができる.
科学分野:
- ウイルス学
- 免疫学
- 構造生物学
背景:
- SARS-CoV-2 パンデミックは,世界的なワクチン接種の努力を必要としています.
- 現在のワクチンは,初期のSARS-CoV-2単離体のスパイクタンパク質を標的にしています.
- 新生変種 (P.1,B.1.351,B.1.1.7) は,ACE2結合部位を含む複数のスパイク変異を有する.
研究 の 目的:
- SARS-CoV-2の変異がACE2結合親和性と中和に与える影響を調査する.
- 新興のSARS-CoV-2変種に対するモノクローナル抗体 (mAb) 222の有効性を評価する.
- mAb 222 中和の構造的基礎と抗体の効能を回復する可能性を理解する.
主な方法:
- SARS-CoV-2のスパイクタンパク質変種の構造分析.
- 変異したスパイクタンパク質に対するACE2結合親和性の評価
- 自然に感染したまたはワクチン接種した個体と単一クローン抗体からの血清を用いた中和測定法.
- mAb222とスパイクタンパク質の相互作用の構造分析
主要な成果:
- P.1 と B.1.351 の変異,特に E484K,K417N/T,および N501Y トリプレットは,ACE2 結合親和性を増加させる.
- P.1はB.1.351と比較して抗体中和に対する抵抗性が低く,非受容体結合ドメイン (RBD) 変異の影響を示しています.
- mAb222は,ACE2結合部位内の標的変異にもかかわらず,P. 1,B.1. 351,B.1. 1.7の変異を効果的に中和する.
- 構造的な洞察は,mAb 222が複数の変異体を中和し,その軽鎖が公共の抗体への中和を回復することを示しています.
結論:
- SARS-CoV-2の変異は,ACE2結合と抗体中和感性に著しく影響する.
- モノクローナル抗体222は,主要なSARS-CoV-2変種に対する広範な中和活性を示しています.
- mAb222スパイク相互作用の構造的な理解は,広範な保護性抗体治療の開発のための基礎を提供します.
さらに関連する動画
関連する概念動画
Cross-reactivity
32.0K
Overview
32.0K
Defense Against Bacterial Pathogens
1.7K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.7K
Antibody Actions
1.7K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.7K
Conjugated Proteins
23.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
23.2K


